Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-02 11:58 am Unchanged | 2022-11-02 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 0 (Unchanged) | Filing History |
| 2022-07-19 5:30 pm Purchase | 2022-07-14 | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 171,973 11.200% | 10,500 (+6.50%) | Filing History |
| 2022-06-10 2:18 pm Purchase | 2021-12-31 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Cambrian BioPharma Inc | 261,574 17.100% | 261,574 (New Position) | Filing History |
| 2022-02-14 3:01 pm Purchase | 2021-12-31 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | H&S INVESTMENTS I LP | 222,081 14.500% | 222,081 (New Position) | Filing History |
| 2022-02-10 5:15 pm Purchase | 2021-12-31 | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 161,473 10.600% | 28,881 (+21.78%) | Filing History |